DBt-10
DBt-10 is a PROTAC degrader that targets and degrades BTK by recruiting DCAF1. It degrades BTK in TMD8 BTK-GFP/mCherry cells with a DC50 of 137 nM. DBt-10 induces CRL4DCAF1-dependent ubiquitination and proteasomal degradation of BTK, and retains BTK-degrading and antiproliferative activities in TMD8 cells that are resistant to CRBN-BTK PROTACs due to loss of CRBN expression. DBt-10 has a high survival window and exhibits extremely weak apoptosis-inducing effects on lymphoma cells. DBt-10 can be used for research on diffuse large B-cell lymphoma.
(Pink: Target protein ligand; Blue: Cereblon ligand (HY-149934); Black: linker).
For research use only. We do not sell to patients.
- Formula: C68H86ClFN16O6
- Molecular Weight:1277.97
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All PROTACs Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
BTK 137 nM (DC50) |
DCAF1 136 nM (IC50) |
DCAF1 147 nM (Kd) |
In Vitro
DBt-10 (0.625-10 μM; 6 h) also reduces BTK in a concentration-dependent manner and induces significant degradation at 2.5 μM[1].
DBt-10 (1 μM; 1-24 h) reduces endogenous BTK protein in TMD8 cells, with obvious degradation occurring at approximately 6 h[1].
DBt-10 (5 µM; 6 h) selectively degrades BTK in TMD8 cells, and global proteomic analysis detects that it only causes extremely mild off-target downregulation of LIMK1[1].
The TR-FRET IC50 of DBt-10 binding to DCAF1 is 0.136 μM, and the IC50 decreases to 0.082 μM after the addition of BTK[1].
The SPR KD of the DBt-10/DCAF1 binary complex is 0.147 μM with a complex half-life of 175 s, whereas the apparent KD of the DCAF1/DBt-10/BTK ternary complex is 0.033 μM with a half-life of 429 s[1].
DBt-10 (24 h) degrades BTK-GFP in TMD8 BTK-GFP/mCherry cells, with a DC50 of 0.137 μM and a maximum BTK reduction level of 94%. Its cell viability GI50 is >25 μM, and the GI50/DC50 ratio is >182.6[1].
DBt-10 (1 µM; 24 h) effectively degrades BTK and inhibits the proliferation of CRBN-resistant TMD8 cells, thereby overcoming acquired resistance to CRBN-based BTK PROTACs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:TMD8 cells
-
Concentration:1 µM
-
Incubation Time:1, 3, 6, 24 h
-
Result:Reduced endogenous BTK, with efficient degradation observed at approximately 6 h.
-
Cell Line:TMD8 cells
-
Concentration:0.625, 1.25, 2.5, 5 and 10 μM
-
Incubation Time:6 h
-
Result:Reduced endogenous BTK in a concentration-dependent manner, with significant degradation at 2.5 μM.
-
Cell Line:TMD8 cells
-
Concentration:Inhibitors: 1 μM for 30 min; DBt-10: 2.5 μM
-
Incubation Time:6 h after DBt-10 addition
-
Result:Rescued BTK degradation with Bortezomib (HY-10227).
Chemical Information
-
Molecular Weight 1277.97
-
Formula C68H86ClFN16O6
-
SMILES
ClC(C=C1)=CC=C1C2(CCCCC2)C3=NC4=CC(N5CCN(C(CCCC(NCCN6CC7(CCN(C(CN8C=C(C9=CC(C(C%10=C(C)C(NC(N%11CC(CC(C)(C)C)(O)C%11)=O)=CC(F)=C%10)=NC=N%12)=C%12N9)C=N8)=O)CC7)OCC6)=O)=O)CC5)=CC=C4C(NCCN)=N3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)